Compumedics Gross Profit
The Gross Profit of Compumedics (CMP.AX) as of Jun 24, 2026 is 27.92 T AUD.In the previous year, Gross Profit was 26.07 T AUD — a change of 7.1% (higher).
Get this data via API
Financial Data API
Gross Profit
27.92 TAUD
YoY
7.1%
Last updated:
Gross Profit of Compumedics is 2026 27.92 T AUD. Gross Profit of Compumedics was 2025 26.07 T AUD. It decreases by 7.1% higher compared to the previous year.
The Compumedics Gross Profit history
3 Years
10 Years
25 Years
Max
GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2006
5,365 base
Jan 1, 2007
5,829 base
Jan 1, 2008
5,747 base
Jan 1, 2009
5,638 base
Jan 1, 2010
5,931 base
Jan 1, 2011
5,732 base
Jan 1, 2012
4,950 base
Jan 1, 2013
5,090 base
Jan 1, 2014
5,282 base
Jan 1, 2015
5,386 base
Jan 1, 2016
5,308 base
Jan 1, 2017
5,535 base
Jan 1, 2018
5,726 base
Jan 1, 2019
5,968 base
Jan 1, 2020
5,136 base
| YEAR | GROSS MARGIN (%) |
|---|---|
| 2030 est | 20,95 |
| 2029 est | 25,47 |
| 2028 est | 28,91 |
| 2027 est | 34,55 |
| 2026 est | 38,71 |
| 2025 | 54,93 |
| 2024 | 52,43 |
| 2023 | 50,91 |
| 2022 | 51,17 |
| 2021 | 53,61 |
| 2020 | 51,36 |
| 2019 | 59,68 |
| 2018 | 57,26 |
| 2017 | 55,35 |
| 2016 | 53,08 |
| 2015 | 53,86 |
| 2014 | 52,82 |
| 2013 | 50,90 |
| 2012 | 49,50 |
| 2011 | 57,32 |
| 2010 | 59,31 |
| 2009 | 56,38 |
| 2008 | 57,47 |
| 2007 | 58,29 |
| 2006 | 53,65 |
Access this data via the Eulerpool API
Compumedics Revenue
Compumedics Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
38.88 M AUD
-1.23 M AUD
-1.6 M AUD
Jan 1, 2007
36.87 M AUD
2.04 M AUD
120,000 AUD
Jan 1, 2008
38.96 M AUD
2.1 M AUD
760,000 AUD
Jan 1, 2009
38.97 M AUD
3.99 M AUD
2.73 M AUD
Jan 1, 2010
32.61 M AUD
2.2 M AUD
420,000 AUD
Jan 1, 2011
30.86 M AUD
1.48 M AUD
80,000 AUD
Jan 1, 2012
27.92 M AUD
-1.29 M AUD
-2.83 M AUD
Jan 1, 2013
27.15 M AUD
-870,000 AUD
-1.49 M AUD
Jan 1, 2014
30.84 M AUD
1.6 M AUD
910,000 AUD
Jan 1, 2015
33.5 M AUD
2.45 M AUD
1.97 M AUD
Jan 1, 2016
37.54 M AUD
3.21 M AUD
3.27 M AUD
Jan 1, 2017
34.42 M AUD
1.42 M AUD
1.31 M AUD
Jan 1, 2018
37 M AUD
3.69 M AUD
2.78 M AUD
Jan 1, 2019
41.51 M AUD
5.35 M AUD
4.02 M AUD
Jan 1, 2020
35.07 M AUD
-329,000 AUD
-5.84 M AUD
Compumedics Margins
Compumedics stock margins
The Compumedics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Compumedics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Compumedics.
3 Years
5 Years
10 Years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
53.65 %
-3.16 %
-4.12 %
Jan 1, 2007
58.29 %
5.53 %
0.33 %
Jan 1, 2008
57.47 %
5.39 %
1.95 %
Jan 1, 2009
56.38 %
10.24 %
7.01 %
Jan 1, 2010
59.31 %
6.75 %
1.29 %
Jan 1, 2011
57.32 %
4.8 %
0.26 %
Jan 1, 2012
49.5 %
-4.62 %
-10.14 %
Jan 1, 2013
50.9 %
-3.2 %
-5.49 %
Jan 1, 2014
52.82 %
5.19 %
2.95 %
Jan 1, 2015
53.86 %
7.33 %
5.88 %
Jan 1, 2016
53.08 %
8.55 %
8.72 %
Jan 1, 2017
55.35 %
4.12 %
3.79 %
Jan 1, 2018
57.26 %
9.98 %
7.52 %
Jan 1, 2019
59.68 %
12.89 %
9.68 %
Jan 1, 2020
51.36 %
-0.94 %
-16.65 %
Compumedics Stock analysis
What does Compumedics do? Compumedics is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Compumedics stock
Gross Profit of Compumedics amounted to 26.07 T AUD 27.92 T
Access this data via the Eulerpool API
Income Statement — Compumedics
All Key Metrics — Compumedics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth